MIP
HAE icon

Marietta Investment Partners’s Haemonetics HAE Stock Holding History

Marietta Investment Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,474
Closed -$205K – 165
2024
Q2 		$205K Hold
2,474
– – 0.04% 156
2024
Q1 		$211K Sell
2,474
-1,090
-31% -$85.5K 0.05% 161
2023
Q4 		$305K Buy
+3,564
New +$308K 0.08% 137

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Marietta Investment Partners's HAE Position: Q3 2024 in Review

Marietta Investment Partners sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 2,474 shares — an estimated $205K sold.

Marietta Investment Partners first reported a position in HAE in Q4 2023 and held it in 3 quarters. The position peaked at $305K in Q4 2023. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • Marietta Investment Partners reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • Marietta Investment Partners sold 2,474 Haemonetics shares in Q3 2024, an estimated $205K.
  • Marietta Investment Partners first reported a position in Haemonetics in Q4 2023 and held it in 3 quarters.
  • Marietta Investment Partners's Haemonetics position peaked at $305K in Q4 2023.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on Marietta Investment Partners's 13F filing for Q3 2024, filed 12 Nov 2024.